Zeph Technologies
Zeph offers a virtual pulmonary rehabilitation program designed to support patients with chronic pulmonary conditions, such as COPD. Their 9-week program utilizes AI and machine learning to create personalized treatment plans, aiming to increase patient adherence and improve quality of life. The solution includes a patient-facing app for training and tracking, providing personalized exercises, mental health support, and educational modules. Clinicians benefit from a dashboard that consolidates patient data, offering insights to enhance telerehab sessions and overall treatment management. The company's mission is to make lung care more accessible and improve patient outcomes, driven by the personal experience of its founders with family members suffering from COPD. Zeph partners with clinicians who accept insurance, making their services more affordable.
Zeph Technologies
Zeph offers a virtual pulmonary rehabilitation program designed to support patients with chronic pulmonary conditions, such as COPD. Their 9-week program utilizes AI and machine learning to create personalized treatment plans, aiming to increase patient adherence and improve quality of life. The solution includes a patient-facing app for training and tracking, providing personalized exercises, mental health support, and educational modules. Clinicians benefit from a dashboard that consolidates patient data, offering insights to enhance telerehab sessions and overall treatment management. The company's mission is to make lung care more accessible and improve patient outcomes, driven by the personal experience of its founders with family members suffering from COPD. Zeph partners with clinicians who accept insurance, making their services more affordable.
TL;DR
Product: AI-powered 9-week remote pulmonary rehabilitation program with patient app and clinician dashboard
Clinical focus: Chronic pulmonary disease / COPD management and remote patient monitoring
Founders: CEO Mimi Gendreau Kigawa and CTO Francis Kigawa
Funding: Early-stage funding (pre-seed/seed), total reported ~USD 500,000
Locations: Team based between Austin, TX and New York City
Company Overview
Problem Domain
Remote pulmonary rehabilitation, COPD and chronic pulmonary disease management, remote patient monitoring
Industry
Health technology / Digital health
Funding Track Record
Reported latest funding on Dec 1, 2023 (pre-seed); public profiles list Antler and Harvard Innovation Labs as investors.
250000
Dealroom lists Antler investing $250K (Jan 2024).
Investor Signal
“Antler; Harvard Innovation Labs”